• Catalan
  • Dutch
  • English
  • German
  • Spanish
Health Outcomes Observatory
  • Home
  • Project
    • About H2O
    • Vision & Objectives
    • Impact
    • Work Packages
    • Governance
  • Participants
    • Partners
    • Associated Collaborators
    • Advisory Boards
  • Observatories
    • What are the Observatories?
    • How do they work?
  • Patients
    • H2O, with and for patients
    • FAQs
    • PROs Leaflet
  • News
    • News
    • Press Releases & Announcements
    • Events
    • Blogs
  • Resources
    • Publications
    • Deliverables
    • Factsheets
  • Contact
  • Search
  • Menu Menu
  • Home
  • Project
    • About H2O
    • Vision & Objectives
    • Impact
    • Work Packages
    • Governance
  • Participants
    • Partners
    • Associated Collaborators
    • Advisory Boards
  • Observatories
    • What are the Observatories?
    • How do they work?
  • Patients
    • H2O, with and for patients
    • FAQs
    • PROs Leaflet
  • News
    • News
    • Press Releases & Announcements
    • Events
    • Blogs
  • Resources
    • Publications
    • Deliverables
    • Factsheets
  • Contact

H2O celebrates its 3rd GAM to share project progress

8th October 2021/in events, news /by h2o

Our October General Assembly was an important milestone for H2O. During the Assembly, we recognised the considerable progress made towards creating the foundation of the H2O project; the result of many months of hard work across the consortium.

The goal for H2O is to create a standardised language for patient reported outcomes (PROs) so that patients have better discussions with their doctors. We believe that this language has the power to provide data which will drive better research, development and decision-making throughout the healthcare system, advancing value based healthcare.

The goal for H2O is to create a standardised language for patient reported outcomes (PROs) so that patients have better discussions with their doctors.

Putting the building blocks in place to achieve this has been a privilege and also a challenge!

During our General Assembly, we were proud to share our progress on a number of fundamental activities. These included;

  • Our approach to creating a standardised language via a Delphi process; a methodologically sound way of reaching consensus. To find out more about how we are defining this language, click here To see the article published in NEJM Catalyst, click here. 
  • Building a governance model which would ensure the safe and ethical storage of the data collected by creating H2O observatories. Stay tuned for more information about the steps we are taking to build a sound governance model.
  • Designing a data infrastructure which balances the needs of technology and ethics; to create ‘networks of trust’. To find out about why partnership in technology is so important to H2O, click here.
  • Creating a business model which will sustain us beyond our funding period in 2025. Stay tuned for more information about H2Os sustainability. In the meantime you can read about the Observatories here.

H2O doesn’t sit in its own bubble; the success of the project relies on working within a complex healthcare environment shaped by policies, economic trends, public debate and a fast-moving post-COVID world.  We strongly believe the momentum is building in our favour, as we see a wider appreciation of the value of data, along with calls for responsible data sharing to forward science. We also see an increasing appetite for PROs amongst healthcare providers and regulators which demands an ever more sophisticated infrastructure for defining and sharing the data sets these PROs produce.

H2O doesn’t sit in its own bubble; the success of the project relies on working within a complex healthcare environment

We brought some of these discussions into our Public Section of the General Assembly though a series of panels;

  • The value of PROs in the consultation room was demonstrated in an extremely engaging keynote speech from Judith F. Baumhauer, M.D., M.P.H., Associate Chair of Academic Affairs and Professor, Department of Orthopaedics at the University of Rochester, Director of the Clinical BioInformatics Core for the UR Health Care System and board of director of Accountable Health Partners, ACO for the Rochester Region. You can read a summary of Dr. Baumhauer speech here or watch full recording on You Tube.
  • Our panel entitled ‘Patient reported outcomes measures in consultations’ included Linetta Koppert, MD.PhD.MSc. Surgical Oncologist at Erasmus MC (The Netherlands), Diane Delnoij, Prof. DR. D.M.J. Endowed chair as professor of ‘Governance of healthcare quality and efficiency’ at the Erasmus School of Health Policy & Management. Scientific officer for the Dutch National Health Care Institute (Zorginstituut Nederland, Evelyn Gross Mrs, CRO for neurodegeneration as a preclinical research associate and board member of the Austrian Crohn’s Colitis Association, Esther Goud, patient.
  • Our panel on’ Data as an Essential Resource’ drew together Peter Singleton, Mr, Information Governance Expert at The European Institute for Innovation through Health Data (i~HD); Karen Marie Lyng, MD, PhD, MBM, MI Head of Department, Department of Data Quality and Registries, The Danish Health Data Authority; Ian Forrester, QC, JD General Court of the European Union 2015 -2020 and Brigit Bauer, Mrs, social Media & Digital Health Expert, Journalist, Speaker and Analyst and Patient Expert. They explored the legal precedents showing data can be viewed as essential to innovation as well as touching on the complexity this brings.

We hope you will continue to follow our journey and be a part of a new way of sharing health data as an essential resource.

This last year have been a huge combined effort from all of our partners and we are excited about the future. We hope you will continue to follow our journey and be a part of a new way of sharing health data as an essential resource.

You can follow our progress and read more about the project by subscribing to our newsletter here.

Tags: GAM
Share this entry
  • Share on Twitter
  • Share on LinkedIn
  • Share by Mail
https://health-outcomes-observatory.eu/wp-content/uploads/2021/10/Help-us-develop-H2O-so-it-leads-to-improved-dialogue-between-patients-and-doctors-to-drive-better-care-725-x-506-px-600-x-500-px.jpg 500 600 h2o https://health-outcomes-observatory.eu/wp-content/uploads/2021/01/H2O-logo-hor-300x98.png h2o2021-10-08 20:01:212021-11-09 13:38:12H2O celebrates its 3rd GAM to share project progress
You might also like
Summary of Dr Judith Baumhauer keynote “PROs: How they influence the care we provide to our patients”
Health administrators, clinicians, and patients discuss their unique experiences with PROs

NEWSLETTER

Sign up to stay informed

Recent Posts

  • Joint statement from H2O and ICHOM announcing a new collaboration agreement
  • Creation of the independent legal entity of the H20 (Health Outcomes Observatory) project in Spain.
  • H2O response to the new European Health Data Space (EHDS)
  • Unleashing the Power of PROS – an H2O Hosted Conversation

ACKNOWLEDGEMENT

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 945345-2. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Trial Nation and JDRF.

About IMI

The Innovative Medicines Initiative is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA). It is working to improve health by speeding up the development of the next generation of medicines, particularly in areas where there is an unmet medical or social need. It works by facilitating collaboration between the key players involved in health research, including universities, research centres, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. IMI is the world’s biggest public-private partnership (PPP) in the life sciences. http://www.imi.europa.eu/

Legal notice
Privacy Policy
Cookies Policy

       




Making the case for Delphi: a robust approach to consensus Summary of Dr Judith Baumhauer keynote “PROs: How they influence the care...
Scroll to top
Non exempt cookies, proprietary cookies and third-party cookies are used to identify the browsing preferences and habits of users and to offer a better experience. Please consult our cookie policy here.
Cookie SettingsAccept all Reject All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT